CoChat
Sign Up
Cited by 7Ion channel regulation and functionCardiac electrophysiology and arrhythmiasErythrocyte Function and Pathophysiology

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cloxyquin activates hTRESK by allosteric modulation of the selectivity filter

Open access
Schreiber, Julian Alexander, Derksen, Anastasia, Goerges, Gunnar, Schütte, Sven, Sörgel, Jasmin, Kiper, Aytug K., Strutz-Seebohm, Nathalie, Ruck, Tobias, Meuth, Sven G., Decher, Niels, Seebohm, Guiscard·2023·Communications Biology
DOI 10.1038/s42003-023-05114-4PMC PMC10354012

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Abstract

The T WIK- re lated s pinal cord K + channel (TRESK, K 2P 18.1) is a K 2P channel contributing to the maintenance of membrane potentials in various cells. Recently, physiological TRESK function was identified as a key player in T-cell differentiation rendering the channel a new pharmacological target for treatment of autoimmune diseases. The channel activator cloxyquin represents a promising lead compound for the development of a new class of immunomodulators. Identification of cloxyquin binding site and characterization of the molecular activation mechanism can foster the future drug development. Here, we identify the cloxyquin binding site at the M2/M4 interface by mutational scan and analyze the molecular mechanism of action by protein modeling as well as in silico and in vitro electrophysiology using different permeating ion species (K + / Rb + ). In combination with kinetic analyses of channel inactivation, our results suggest that cloxyquin allosterically stabilizes the inner selectivity filter facilitating the conduction process subsequently activating hTRESK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-023-05114-4

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. Wiedmann, F., Frey, N. & Schmidt, C. Two-pore-domain potassium (K2P-) channels: cardiac expression patterns and disease-specific remodelling processes. Cells 10, 2914 (2021). · DOI
  2. Ehling, P., Cerina, M., Budde, T., Meuth, S. G. & Bittner, S. The CNS under pathophysiologic attack—examining the role of K2P channels. Pflug. Arch. 467, 959–972 (2015). · DOI
  3. Cohen, A., Ben-Abu, Y. & Zilberberg, N. Gating the pore of potassium leak channels. Eur. Biophys. J. 39, 61–73 (2009). · DOI
  4. Lotshaw, D. P. Biophysical, pharmacological, and functional characteristics of cloned and native mammalian two-pore domain K+ channels. Cell Biochem. Biophys. 47, 209–256 (2007). · DOI
  5. Blin, S. et al. Tandem pore domain halothane-inhibited K+channel subunits THIK1 and THIK2 assemble and form active channels. J. Biol. Chem. 289, 28202–28212 (2014). · DOI
  6. Berg, A. P., Talley, E. M., Manger, J. P. & Bayliss, D. A. Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J. Neurosci. 24, 6693–6702 (2004). · DOI
  7. Natale, A. M., Deal, P. E. & Minor, D. L. Structural Insights into the mechanisms and pharmacology of K2P potassium channels. J. Mol. Biol. 433, 166995 (2021). · DOI
  8. Enyedi, P. & Czirják, G. Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol. Rev. 90, 559–605 (2010). · DOI
  9. Zhang, Q. et al. ‘C-type’ closed state and gating mechanisms of K2P channels revealed by conformational changes of the TREK-1 channel. J. Mol. Cell Biol. 14, 1–20 (2022). · DOI
  10. Proks, P. et al. Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate. J. Gen. Physiol. 153, 1–13 (2021). · DOI
  11. Lolicato, M. et al. K2Pchannel C-type gating involves asymmetric selectivity filter order-disorder transitions. Sci. Adv. 6, 1–14 (2020). · DOI
  12. Nematian-Ardestani, E. et al. Selectivity filter instability dominates the low intrinsic activity of the TWIK-1 K2P K+ channel. J. Biol. Chem. 295, 610–618 (2020). · DOI
  13. Kopec, W., Rothberg, B. S. & de Groot, B. L. Molecular mechanism of a potassium channel gating through activation gate-selectivity filter coupling. Nat. Commun. 10, 1–15 (2019). · DOI
  14. Bagriantsev, S. N., Peyronnet, R., Clark, K. A., Honoré, E. & Minor, D. L. Multiple modalities converge on a common gate to control K2P channel function. EMBO J. 30, 3594–3606 (2011). · DOI
  15. Piechotta, P. L. et al. The pore structure and gating mechanism of K2P channels. EMBO J. 30, 3607–3619 (2011). · DOI
  16. Cohen, A., Ben-Abu, Y., Hen, S. & Zilberberg, N. A novel mechanism for human K2P2.1 channel gating. J. Biol. Chem. 283, 19448–19455 (2008). · DOI
  17. Czirják, G., Tóth, Z. E. & Enyedi, P. The two-pore domain K+ Channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J. Biol. Chem. 279, 18550–18558 (2004). · DOI
  18. Schreiber, J. A., Düfer, M. & Seebohm, G. The special one: architecture, physiology and pharmacology of the TRESK channel. Cell. Physiol. Biochem. 56, 663–684 (2022). · DOI
  19. Lengyel, M., Czirják, G. & Enyedi, P. TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore. PLoS One 13, 1–16 (2018). · DOI
  20. Braun, G., Nemcsics, B., Enyedi, P. & Czirják, G. Tresk background K+ channel is inhibited by PAR-1/MARK microtubule affinity-regulating kinases in Xenopus oocytes. PLoS One 6, 1–10 (2011). · DOI
  21. Czirják, G. & Enyedi, P. TRESK background K+ channel is inhibited by phosphorylation via two distinct pathways. J. Biol. Chem. 285, 14549–14557 (2010). · DOI
  22. Kim, G. T. et al. Upregulation of tresk channels contributes to motor and sensory recovery after spinal cord injury. Int. J. Mol. Sci. 21, 1–15 (2020). · DOI
  23. Kang, D. & Kim, D. TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons. Am. J. Physiol. Cell Physiol. 291, 138–146 (2006). · DOI
  24. Guo, Z. & Cao, Y. Q. Over-expression of TRESK K+ channels reduces the excitability of trigeminal ganglion nociceptors. PLoS One 9, 1–13 (2014).
  25. Lalic, T. et al. TRESK is a key regulator of nocturnal suprachiasmatic nucleus dynamics and light adaptive responses. Nat. Commun. 11, 1–11 (2020). · DOI
  26. Huang, W. et al. TRESK channel contributes to depolarization-induced shunting inhibition and modulates epileptic seizures. Cell Rep. 36, 109404 (2021). · DOI
  27. Pettingill, P. et al. A causal role for TRESK loss of function in migraine mechanisms. Brain 142, 3852–3867 (2019). · DOI
  28. Zhou, J. et al. Reversal of TRESK downregulation alleviates neuropathic pain by inhibiting activation of gliocytes in the spinal cord. Neurochem. Res. 42, 1288–1298 (2017). · DOI
  29. Ruck, T. et al. K2P18.1 translates T cell receptor signals into thymic regulatory T cell development. Cell Res. 32, 72–88 (2022). · DOI
  30. Wright, P. D. et al. Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK. Biochem. Biophys. Res. Commun. 441, 463–468 (2013). · DOI
  31. Lengyel, M., Dobolyi, A., Czirják, G. & Enyedi, P. Selective and state-dependent activation of TRESK (K 2P 18.1) background potassium channel by cloxyquin. Br. J. Pharm. 174, 2102–2113 (2017). · DOI
  32. Schewe, M. et al. A non-canonical voltage-sensing mechanism controls gating in K2P K+ channels. Cell 164, 937–949 (2016). · DOI
  33. Sano, Y. et al. A novel two-pore domain K+ Channel, TRESK, is localized in the spinal cord. J. Biol. Chem. 278, 27406–27412 (2003). · DOI
  34. Lengyel, M. et al. Chemically modified derivatives of the activator compound cloxyquin exert inhibitory effect on TRESK (K2P18.1) background potassium channel. Mol. Pharm. 95, 652–660 (2019). · DOI
  35. Schewe, M. et al. A pharmacological master key mechanism that unlocks the selectivity filter gate in K channels. Science (1979) 363, 875–880 (2019).
  36. Wicha, S. G., Chen, C., Clewe, O. & Simonsson, U. S. H. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions. Nat. Commun. 8, 2129 (2017). · DOI
  37. Zimmermann, M. O., Lange, A., Zahn, S., Exner, T. E. & Boeckler, F. M. Using surface scans for the evaluation of halogen bonds toward the side chains of aspartate, asparagine, glutamate, and glutamine. J. Chem. Inf. Model. 56, 1373–1383 (2016). · DOI
  38. Lees, P., Cunningham, F. M. & Elliott, J. Principles of pharmacodynamics and their applications in veterinary pharmacology. J. Vet. Pharm. Ther. 27, 397–414 (2004). · DOI
  39. Andersen, N., Corradi, J., Sine, S. M. & Bouzat, C. Stoichiometry for activation of neuronal α7 nicotinic receptors. Proc. Natl. Acad. Sci. USA 110, 20819–20824 (2013). · DOI
  40. Hazan, A., Kumar, R., Matzner, H. & Priel, A. The pain receptor TRPV1 displays agonist-dependent activation stoichiometry. Sci. Rep. 5, 12278 (2015). · DOI
  41. Bagriantsev, S. N., Clark, K. A. & Minor, D. L. Metabolic and thermal stimuli control K 2P 2.1 (TREK-1) through modular sensory and gating domains. EMBO J. 31, 3297–3308 (2012). · DOI
  42. Egwolf, B. & Roux, B. Ion selectivity of the KcsA channel: a perspective from multi-ion free energy landscapes. J. Mol. Biol. 401, 831–842 (2010). · DOI
  43. Valiyaveetil, F. I., Sekedat, M., MacKinnon, R. & Muir, T. W. Structural and functional consequences of an amide-to-ester substitution in the selectivity filter of a potassium channel. J. Am. Chem. Soc. 128, 11591–11599 (2006). · DOI
  44. Schreiber, J. A. et al. A benzodiazepine activator locks Kv7.1 channels open by electro-mechanical uncoupling. Commun. Biol. 5, 301 (2022). · DOI
  45. Morais-Cabral, J. H., Zhou, Y. & Mackinnon, R. Energetic optimization of ion conduction rate by the K selectivity filter. Nature 414, 37–42 (2001). · DOI · Paper page
  46. Seebohm, G. Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels. J. Physiol. 552, 369–378 (2003). · DOI
  47. Zhou, Y. & MacKinnon, R. The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. J. Mol. Biol. 333, 965–975 (2003). · DOI
  48. Lam, Y. L., Zeng, W., Sauer, D. B. & Jiang, Y. The conserved potassium channel filter can have distinct ion binding profiles: structural analysis of rubidium, cesium, and barium binding in NaK2K. J. Gen. Physiol. 144, 181–192 (2014). · DOI
  49. García, G., Méndez‐Reséndiz, K. A., Oviedo, N. & Murbartián, J. PKC‐ and PKA‐dependent phosphorylation modulates TREK‐1 function in naïve and neuropathic rats. J. Neurochem. 157, 2039–2054 (2021). · DOI
  50. Harleton, E. et al. Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1). J. Biol. Chem. 288, 2829–2838 (2013). · DOI
  51. Kréneisz, O., Benoit, J. P., Bayliss, D. A. & Mulkey, D. K. AMP-activated protein kinase inhibits TREK channels. J. Physiol. 587, 5819–5830 (2009). · DOI
  52. Ivorra, I., Alberola-Die, A., Cobo, R., González-Ros, J. M. & Morales, A. Xenopus oocytes as a powerful cellular model to study foreign fully-processed membrane proteins. Membranes (Basel) 12, 986 (2022). · DOI
  53. Bhatt, M. et al. The “www” of xenopus laevis oocytes: the why, when, what of xenopus laevis oocytes in membrane transporters research. Membranes (Basel) 12, 927 (2022). · DOI
  54. Dilek, M. et al. Activation of TRESK background potassium channels by cloxyquin exerts protective effects against excitotoxic-induced brain injury and neuroinflammation in neonatal rats. J Neuroimmunol 368, 577894 (2022). · DOI
  55. Lolicato, M. et al. K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site. Nature 547, 364–368 (2017). · DOI
  56. Schreiber, J. A. et al. A common mechanism allows selective targeting of GluN2B subunit-containing N-methyl-D-aspartate receptors. Commun. Biol. 2, 420 (2019). · DOI
  57. Börgel, F. et al. Synthesis and pharmacological evaluation of enantiomerically pure GluN2B selective NMDA receptor antagonists. ChemMedChem. 13, 1580–1587 (2018). · DOI
  58. Varadi, M. et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022). · DOI · Paper page
  59. Krieger, E. & Vriend, G. YASARA View—molecular graphics for all devices—from smartphones to workstations. Bioinformatics 30, 2981–2982 (2014). · DOI
  60. Debiec, K. T. et al. Further along the road less traveled: AMBER ff15ipq, an original protein force field built on a self-consistent physical model. J. Chem. Theory Comput. 12, 3926–3947 (2016). · DOI
  61. Hooft, R. W., Sander, C. & Vriend, G. Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins 26, 363–376 (1996). · DOI
  62. Krieger, E., Dunbrack, R. L., Hooft, R. W. W. & Krieger, B. Assignment of protonation states in proteins and ligands: combining pK a prediction with hydrogen bonding network optimization. Methods Mol. Biol. 819, 405–421 (2012). · DOI
  63. Krieger, E., Nielsen, J. E., Spronk, C. A. E. M. & Vriend, G. Fast empirical pKa prediction by Ewald summation. J. Mol. Graph. Model. 25, 481–486 (2006). · DOI
  64. Günl, F. et al. The ubiquitination landscape of the influenza A virus polymerase. Nat. Commun. 14, 787 (2023). · DOI

Metadata

Authors
Schreiber, J. A., Derksen, A., Goerges, G., Schütte, S., Sörgel, J., Kiper, A. K., Strutz-Seebohm, N., Ruck, T., Meuth, S. G., Decher, N., & Seebohm, G.
Affiliations
  • University of Münster (DE)
  • University Hospital Münster (DE)
  • Philipps University of Marburg (DE)
  • Heinrich Heine University Düsseldorf (DE)
Corresponding author
Schreiber, Julian Alexander
ORCID
Venue
Communications Biology
Publisher
Springer Science and Business Media LLC
Published
2023-07-18
Volume
6
Issue
1
Pages
745-745
ISSN
2399-3642 (ISSN-L)
DOI
10.1038/s42003-023-05114-4
PMC
PMC10354012
OpenAlex
W4384661609
Cited by
7
References
1
Citations by year
2026: 3 · 2025: 3 · 2024: 1
FWCI
0.62
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • URN:NBN Resolver for Germany & Switzerland (German National Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Universitäts- und Landesbibliothek Münster (cc-by)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Physiology (medical) › Erythrocyte Function and Pathophysiology
Keywords
TRESK, K2P channels, allosteric modulation, selectivity filter, channel activation, immunomodulators, autoimmune disease, T cell differentiation, channel inactivation kinetics
MeSH terms
Binding Sites, Chloroquinolinols, Membrane Potentials, Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review